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Abstract 
Background: In Japan, the legislation directing treatment of offenders with psychiatric 
disorders was enacted in 2005. Neuropsychological impairment is highly related to 
functional outcomes in patients with psychiatric disorders, and several studies have 
suggested an association between neuropsychological impairment and violent behaviors. 
However, there have been no studies of neuropsychological impairment in forensic 
patients covered by the Japanese legislation. This study is designed to examine the 
neuropsychological characteristics of forensic patients in comparison to healthy controls 
and to assess the relationship between neuropsychological impairment and violence 
risk. 
Methods: Seventy-one forensic patients with psychiatric disorders and 54 healthy 
controls (matched by age, gender, and education) were enrolled. The CogState Battery 
(CSB) consisting of eight cognitive domains, the Iowa Gambling Task (IGT) to test 
emotion-based decision making, and psychological measures of violence risk including 
psychopathy were used.  
Results: Forensic patients exhibited poorer performances on all CSB subtests and the 
IGT than controls. For each group, partial correlational analyses indicated that poor IGT 
performance was related to psychopathy, especially antisocial behavior. In forensic 
patients, the CSB composite score was associated with risk factors for future violent 
behavior, including stress and noncompliance with remediation attempts.  
Conclusion: Forensic patients with psychiatric disorders exhibit a wide range of 
neuropsychological impairments, and these findings suggest that neuropsychological 
impairment may increase the risk of violent behavior. Therefore, the treatment of 
neuropsychological impairment in forensic patients with psychiatric disorders is 
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necessary to improve functional outcomes as well as to prevent violence. 
Introduction 
In Japan, the Act on Medical Care and Treatment for Persons Who Have Caused Serious 
Cases Under the Condition of Insanity (Medical Treatment and Supervision Act, or 
MTS Act) came into force on July 15, 2005, with the Ministry of Justice and the 
Ministry of Health, Labour and Welfare responsible for its implementation. The MTS 
Act encompasses individuals who have committed a serious violent offence (e.g., 
homicide, injury, arson, robbery, or sexual assault) while in a state of insanity or 
diminished responsibility. If a court panel decides to order hospitalization, the offender 
is detained in a designated psychiatric facility. The aim of the forensic mental health 
services directed by the MTS Act is to improve offenders’ reintegration in society and 
prevent recidivism [1].  
Neuropsychological impairment, including cognitive impairment, is common in 
patients suffering from a variety of psychiatric disorders, and the impairment can affect 
multiple cognitive domains in comparison to healthy control subjects [2]. Treatment of 
cognitive impairment in patients with psychiatric disorders is one of the most important 
aspects in the field of mental health [3-7]. Neuropsychological impairment is also 
highly related to functional outcomes, such as life satisfaction [8], social problem 
solving, successful performance of daily activities [9, 10], and returning to work and 
school [11]. The recovery rate is inversely correlated with the severity of impairment, 
and even in those patients who appear to have substantially recovered, residual 
neuropsychological impairment compromises real-world functioning [2]. Furthermore, 
numerous studies using incarcerated offenders or people with antisocial or psychopathic 
symptoms have demonstrated that neuropsychological impairment is associated with 
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violent behavior and that impairment in executive functioning and/or social recognition 
can lead to cognitive biases that increase the chances of violent behavior [12–14].  
Nonetheless, there have been no studies indicating the neuropsychological 
characteristics in forensic psychiatric patients since the MTS Act took effect in Japan. 
The aims of the present study are (1) to examine the neuropsychological characteristics 
of Japanese forensic psychiatric patients in comparison with nonviolent healthy controls 
and (2) to assess the relationship between performance of neuropsychological tests and 
risk factors for violence, including psychopathic personality traits. This study is 
designed to capture broad domains of neuropsychological functioning and to assess both 
cognitive and emotional functions.  
The Japanese-language version of the CogState Battery (CSB) and the Iowa 
Gambling Task (IGT) are used as measures. The CSB provides a brief standardized 
assessment of broad cognitive domains including verbal learning, processing speed, 
attention/vigilance, working memory, visual learning, reasoning and problem solving, 
and social cognition [15]. The IGT assesses the emotional aspects of decision making in 
ambiguous situations [16] and simulates real-life decision making under conditions of 
reward and punishment and of uncertainty [17].  
Materials and Methods 
Participants  
The patients were recruited from three designated forensic hospital units that provide 
services under the MTS Act: the National Hospital Organization Shimofusa Psychiatric 
Medical Center (located in Chiba, Japan), National Center of Neurology and Psychiatry 
Hospital, and Tokyo Metropolitan Matsuzawa Hospital (both located in Tokyo, Japan). 
The healthy controls had no history of serious violence or psychiatric disorders and 
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were recruited through an advertisement and by a dispatch service company (Souken 
Inc., http://www.souken-lab.co.jp/). We contacted a total of 144 individuals, of whom 
125 gave informed consent to the study and complied with all procedures. The final 
sample comprised 71 forensic patients and 54 healthy controls. 
The 71 forensic patients were diagnosed using the International Statistical 
Classification of Diseases, tenth revision (ICD-10; World Health Organization, 1992) 
by their consulting psychiatrist; the diagnoses were confirmed by another psychiatrist at 
a unit meeting. Nine patients were diagnosed with psychotic disorders due to 
psychoactive substance use (coded as F1); 61 with schizophrenia, schizoaffective 
disorder, or delusional disorders (coded as F2); and 1 with mood disorder (coded as F3). 
Twenty-three of the 71 patients had committed homicide, while 33 had been charged 
with injury, 11 with arson, 1 with robbery, and 3 with sexual assault. All patients were in 
the convalescent or rehabilitative (not the acute) stage of treatment. Four were treated 
with a single first-generation antipsychotic medication, 27 with a single 
second-generation antipsychotic medication, and 40 with a combination of 
antipsychotic drugs.  
The 54 healthy controls were screened with clinical interviews to ensure that they 
did not suffer from psychiatric disorders. We made a concerted effort to recruit 
community participants who would match the forensic patients with regard to age, 
male-female ratio, smoker-nonsmoker ratio, and level of educational achievement. 
Inclusion criteria for all participants in both groups included proficiency in the 
Japanese language, normal or corrected-to-normal visual function, and a minimum of 
ninth-grade education. Exclusion criteria for all participants in both the groups included 
any current or past histories of head injury, cerebral vascular disorders, or epilepsy. 
Prior to the commencement of the study, all participants provided written 
 5 
informed consent after receiving a full explanation regarding the nature of the study and 
the potential risks and benefits of study participation. A researcher assessed their 
capacity to consent by three questions based on Palmer et al. [18]: (1) “What is the 
purpose of the study?” (2) “What are the risks?” and (3) “What are the benefits?” The 
individuals who had compromised capacity to consent were excluded from the study. 
The study was approved by the relevant ethics committee of each institute and 
was performed in accordance with the Declaration of Helsinki II. The ethics committees 
of each institute were the Ethics Committee of Chiba University Graduate School of 
Medicine, the Ethics Committee of National Hospital Organization Shimofusa 
Psychiatric Medical Center, the Ethics Committee of National Center of Neurology and 
Psychiatry, and the Ethics Committee of Tokyo Metropolitan Matsuzawa Hospital. 
Demographic information 
For both groups, information on sex, age, years of education, and smoking status were 
collected. For the forensic patients, information on duration of illness, duration of 
untreated psychosis, and dosage of medications was also obtained. To assess premorbid 
intellectual quotient (IQ), the Japanese Adult Reading Scale, which is the Japanese 
version of the National Adult Reading Test (JART) [19], was used with both the groups.  
Clinical measures 
The World Health Organization (WHO) Quality of Life instrument (WHOQOL-26) is a 
26-item, self-administered questionnaire and a shortened version of the WHOQOL-100 
scale, which measures the four domains of physical health and well-being, 
psychological health and well-being, social relationships, and environment. Higher 
scores represent a better quality of life. The Positive and Negative Syndrome Scale 
(PANSS) was used to measure the severity of symptoms in the patients. The PANSS is a 
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30-item, clinician-rated instrument of positive, negative, and general psychopathology 
symptoms; each item is scored from 1 (absent) to 7 (severe), with a total score ranging 
from 30 to 210 [20].  
Violence risk measures 
The Psychopathy Checklist-Revised (PCL-R) assesses inferred personality traits and 
behaviors related to psychopathy, using information from a semi-structured interview 
and records. The PCL-R consists of 20 items; each item is scored as 0 (absent), 1 
(present to some degree), or 2 (fully present), with a total score ranging from 0 to 40. 
Factor 1 of the PCL-R measures emotional detachment, lack of empathy and remorse, 
fearlessness, and insensitivity to punishment, whereas Factor 2 covers impulsiveness 
and antisocial lifestyle [21].  
For the forensic patients, the Historical Clinical Risk Management-20 (HCR-20) 
was also used to assess violence risk based on information from a semi-structured 
interview and records. The HCR-20 includes 20 items and 3 subscales; each item is 
scored as 0 (not present), 1 (possibly or partially present), or 2 (definitely present), with 
a total score ranging from 0 to 40. Ten items relate to historical (H) or static risk factors 
(e.g., previous violence, age at first violent incident), five cover clinical (C) or current 
risk factors (e.g., lack of insight, impulsivity), and five concern risk management (R) or 
future-oriented factors (e.g., lack of personal support, stress) [22].  
The CogState Battery (CSB), Japanese-language version, is a rapid, automatically 
administered, computerized battery that assesses verbal learning and memory (using the 
International Shopping List Task, or ISLT), visual learning and memory (One Card 
Learning Task, OCL), speed of processing (Detection Task, DET), attention and 
vigilance (Identification Task, IDN), visual working memory (Two Back Task, TWOB), 
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spatial working memory (Continuous Paired Association Learning Task, CPAL), 
reasoning, problem solving, and error monitoring (Groton Maze Learning Task, GML), 
and social cognition (Social Emotional Cognition Task, SECT) [15]. These tasks were 
presented on a green screen, along with standardized instructions given by a trained 
researcher before the commencement of each task, to ensure that all participants 
completely understood and followed the rules. The results were uploaded to a secure 
account on the CogState server site (http://www.cogstate.com), where data were 
calculated and normalized. The primary measure from each task of the CSB was 
standardized by creating Z-scores. The mean for the control group was set at zero and 
the standard deviation at one, following the methodological procedure used by Keefe et 
al. [23]. A composite score was calculated by averaging all Z-scores from the eight 
primary measures contained in the CSB.  
The IGT was described in detail in a previous study [16]. Briefly, the task goal is 
to maximize the profit from a loan granted in play money. The participant is required to 
make a series of 100 card selections from one of four card decks (A, B, C, and D). Each 
selection is followed by the showdown of a reward and a penalty. The reward and 
penalty schedules are predetermined but not explained to the participant in advance. 
Decks A and B yield high immediate rewards but carry the risk of much higher 
long-term penalties, which will result in a net loss in the long run; they are thus referred 
to as disadvantageous decks. Decks C and D yield small immediate rewards but even 
smaller long-term penalties, resulting in a net long-term gain (and making them 
advantageous decks). We developed a computerized Japanese version of the IGT in 
strict compliance with the original version [24]. The only substantive difference from 
the original task was that the play money was converted from U.S. dollars to Japanese 
yen. After they completed the task, the participants were asked which decks they 
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considered advantageous. IGT performance was described as a net score calculated by 
subtracting the number of cards selected from the two disadvantageous decks (A + B) 
from the number selected from the two advantageous decks (C + D). Higher scores 
reflected more advantageous decision-making performance on the task. 
Statistical analyses 
SPSS for Windows, version 19 (SPSS Inc., Chicago, USA), was used for all analyses. 
Student’s t-test and Fisher’s exact test were used to examine differences between groups. 
For comparison of the IGT scores between groups, a two-way repeated ANOVA (2 
groups × 5 blocks of 20 trials) was performed, and multiple analyses by post-hoc 
Bonferroni testing were used. ANCOVAs were performed if potential relationships 
between demographic data and scores of neuropsychological, clinical, or violence risk 
measures were observed in preliminary correlational analyses. Partial correlational 
analyses were performed separately for the forensic and control groups, respectively, to 
evaluate relationships between neuropsychological test performance and violence risk 
scores. Demographic and clinical variables were controlled because of the possibility 
that these variables might affect neuropsychological functions and violence risk. For the 
healthy group, the controlled variables included age, sex, years of education, smoking 
status, premorbid IQ, and QOL score; for the patient group, all these variables plus 
duration of illness, duration of untreated psychosis, dosage of medications, and PANSS 
total score were controlled. Values of p < 0.05 were considered as indicating statistical 
significance. 
Results 
Comparing forensic patients with controls on demographic, 
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neuropsychological, clinical, and violence risk measures 
Information on demographic and clinical domains and violence risk in both forensic 
patients and healthy controls is presented in Table 1. On the demographic measures, a 
series of t-tests and Fisher’s exact tests indicated that the two groups were matched for 
age (p = 0.729), sex (p = 0.601), years of education (p = 0.329), and smoking status (p = 
1.000), but the mean premorbid IQ in the forensic patients was significantly lower than 
in the controls (p < 0.001). To estimate the potential relationship of premorbid IQ to 
violence risk and clinical and neuropsychological measures, the correlations were 
calculated on the whole sample (N = 125) before comparing the two groups on these 
measures. There were significant correlations between premorbid IQ and scores on all 
measures (QOL, r = 0.37, p < 0.001; PCL-R, r = −0.29, p = 0.001; CSB composite 
score, r = 0.49, p < 0.001) except IGT net score (r = 0.15, p = 0.95).  
 
Table 1. Characteristics of demographic and clinical domains and violence risk in 
forensic patients and healthy controls  
  Controls (n = 54) Patients (n = 71) Statistics p value 
Demographic domains     
Age (years) 42.06 ± 11.43 (23–69) 42.79 ± 11.92 (21–74) t = -0.35a 0.729 
Sex (male/female) 48/6 60/11 χ2 = 0.50b 0.601 
Education (years) 12.76 ± 2.66 (9–18) 12.30 ± 2.58 (9–21) t = 0.98a 0.329 
Smoking status 
(current/non-smoker) 
32/22 41/30 χ2 = 0.03b 1.000 
Premorbid IQ 106.04 ± 9.83 (86–122) 99.45 ± 10.69 (78–120) t = 3.53a < 0.001 
Duration of illness (years)   18.07 ± 9.87 (4–43)     
Duration of untreated 
psychosis (years) 
  4.08 ± 5.92 (0–25)     
Dosage of medications     
Chlorpromazine equivalents   756.97 ± 598.22 (13–2902)     
 10 
(mg) 
Diazepam equivalents (mg)   11.33 ± 13.80 (0–70)     
Biperiden equivalents (mg)   1.70 ± 2.33 (0–12)     
Clinical domains     
WHO-QOL26 score 3.36 ± 0.51 (1.62–4.23) 2.98 ± 0.57 (1.69–4.88) F = 7.88c 0.006 
PANSS total score   56.97 ± 19.59 (30–117)     
Violence risk     
PCL-R total score 5.24 ± 3.96 (0–18) 11.25 ± 4.72 (1–23) F = 45.39c < 0.001 
HCR-20 total score   18.82 ± 4.12 (10–27)     
Data are the mean ± S.D. Parenthesis is the range. 
a 
Student's t-teat 
b 
Fisher's exact test 
c 
ANCOVA with premorbid IQ as a covariable 
 
Due to the potential effect of premorbid IQ on QOL and PCL-R scores, 
ANCOVAs with premorbid IQ as a covariable were conducted. In this analysis, the 
forensic patients had more severe problems on the QOL (F = 7.88, p = 0.006) and 
higher scores on the PCL-R (F = 45.39, p < 0.001) than the controls (Table 1).  
With regard to the CSB, the ANCOVAs with premorbid IQ as a covariable 
indicated that the scores on the ISL (F = 51.86, p < 0.001), TWOB (F = 8.94, p = 0.003), 
IDN (F = 16.44, p < 0.001), DET (F = 11.82, p < 0.001), CPAL (F = 4.45, p = 0.037), 
OCL (F = 5.95, p = 0.016), and SECT (F = 5.72, p = 0.018), as well as the composite 
score (F = 29.85, p < 0.001), were lower in forensic patients than in controls. Since 
regression lines of group factor and premorbid IQ to the GML score were not parallel 
(group–premorbid IQ interaction was significant), a t-test for the GML score was 
performed without premorbid IQ as a covariable. Forensic patients had lower scores on 
the GML (t = 4.63, p < 0.001), indicating that they exhibited poorer performances on all 
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CSB domains than controls (Fig 1). 
 
 
Fig 1. Magnitude of impairment in forensic patients relative to healthy controls on 
each CSB measure. Mean ± SD of Z-scores are given. Z-score was created by setting 
controls’ mean to zero and SD to one. Abbreviation: ISL International Shopping List 
Task, GML Groton Maze Learning Task, TWOB Two Back Task, IDN Identification 
Task, DET Detection Task, CPAL Continuous Paired Association Task, OCL One Card 
Learning Task, SECT Social Emotional Cognitive Task. * p < 0.05, ** p < 0.01, *** p 
< 0.001. 
 
As for performance on the IGT, a two-way repeated ANOVA (2 groups × 5 blocks 
of 20 trials) was conducted without premorbid IQ as a covariable due to the lack of 
correlation between the two in the preliminary correlation analysis. The ANOVA 
demonstrated a significant main effect for blocks (F = 16.51, p < 0.001), with 
participants becoming increasingly risk-aversive over time. A primary effect for groups 
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was marginally significant (F = 3.90, p = 0.051). The block–group interaction was 
significant (F = 3.30, p = 0.011), with controls indicating a greater tendency to become 
more risk-aversive over time than forensic patients. Post-hoc Bonferroni analysis 
showed that forensic patients differed significantly from controls in block 4 (p = 0.004) 
and in block 5 (p = 0.022) (Fig 2). 
 
 
Fig 2. The IGT net scores for the 5 blocks for forensic patients and healthy 
controls. Mean ± SD are given. * p < 0.05, ** p < 0.01. 
 
Furthermore, we examined the effect of diagnosis categories or criminal types on 
neuropsychological domains, although the number of participants in some diagnosis 
categories or criminal types was small (data not shown). Due to the very small number 
of participants, patients coded as F3 (n = 1) or who committed robbery (n = 1) or sexual 
assault (n = 3) were excluded from each analysis. F1 patients (n = 9) exhibited lower 
scores than the control group on the IDN, ISL, and CSB composite score, and F2 
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patients (n = 61) had lower scores than controls on all neuropsychological domains 
except the CPAL, SECT, and IGT net score. There were no differences between F1 and 
F2 patients on all tests. Patients who had committed homicide (n = 23) were 
significantly lower than controls on the DET, IDN, TWOB, ISL, and CSB composite 
score; the injury group (n = 33) had lower IDN, GML, ISL, CPAL, and composite 
scores; the arson group (n = 11) had lower IDN and ISL scores than controls. 
Furthermore, there were no differences among these three criminal types on all tests.  
Partial correlation analyses between neuropsychological 
functions and violence risk 
Partial correlation analyses were performed with the data from both groups, controlling 
for demographic and clinical variables. For the control group, Table 2 indicates 
significant negative correlations between IGT performance and both PCL-R Factor 1 (r 
= −0.29, p = 0.047) and Factor 2 (r = −0.35, p = 0.018). With regard to the forensic 
patients, Table 3 shows a significant negative correlation of IGT performance with 
PCL-R Factor 2 (r = −0.30, p = 0.031). These results indicated that participants with 
high PCL-R scores exhibited more risky decision making in an ambiguous situation. 
Negative correlations between the CSB composite score and both the PCL-R Factor 2 
score (r = −0.27, p = 0.054) and HCR-20 R score (r = −0.27, p = 0.052) were 
marginally significant in forensic patients.  
 
Table 2. Partial correlations between scores of measures on violence risk and 
neuropsychological performances in healthy controls 
 CSB composite score IGT net score 
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Measures r p value r p value 
PCL-R total  -0.07 0.660 -0.37 0.010 
Personal/affective factor 
(Factor 1) 
0.14 0.355 -0.29 0.047 
Antisocial deviant factor 
(Factor 2) 
-0.19 0.188 -0.35 0.018 
Partial correlation coefficients were calculated after controlling for age, sex, education 
years, smoking status, premorbid IQ, and QOL score. 
 
Table 3. Partial correlations between scores of measures on violence risk and 
neuropsychological performances in forensic patients 
 CSB composite score IGT net score 
Measures r p value r p value 
PCL-R total -0.13 0.346 -0.28 0.045 
personal/affective factor 
(Factor 1) 
-0.10 0.482 -0.08 0.582 
antisocial deviant factor 
(Factor 2) 
-0.27 0.054 -0.33 0.017 
HCR-20 total -0.12 0.407 -0.16 0.258 
Historical (H) factor -0.03 0.807 -0.01 0.932 
Clinical (C) factor -0.01 0.973 -0.19 0.165 
Risk management (R) factor -0.27 0.052 -0.16 0.242 
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Partial correlation coefficients were calculated after controlling for age, sex, education 
years, smoking status, premorbid IQ, illness duration, duration of untreated psychosis, 
the dosage of medications, QOL score, and PANSS total score. 
 
Discussion 
This is the first study to investigate neuropsychological characteristics and their 
associations with violence risk in forensic psychiatric patients covered by the MTS Act 
in Japan.  
We used the PCL-R and HCR-20 for violence risk assessment. Zhou’s review 
suggested that the validity of these instruments developed in the West is poorer for 
Chinese samples than that for Western ones [25]. However, their review included only 
two PCL-R and three HCR-20 studies also estimated the validity only in Chinese 
samples but not in other Asian samples, including Japanese ones. Furthermore, the 
PCL-R can predict aggression in Korean inmates [26], and the HCR-20 demonstrates 
similar predictive accuracy across Asian-American (including Japanese), Native 
Hawaiian, and Euro-American samples [27]. Taken together, we believe that the PCL-R 
and HCR-20 could be applicable for Asian samples, including Japanese ones. 
Forensic patients exhibited higher scores of violence risk (illustrated by higher 
PCL-R scores) although their mean PCL-R score did not exceed 30, which is considered 
the cut-off point for the label of psychopathy. This difference between the groups was 
not surprising, as approximately 20–30% of patients with schizophrenia have 
psychopathic traits in foreign forensic psychiatric settings [28, 29]. Accumulating 
evidence suggests that individuals with psychiatric disorders are at increased risk for 
violent offending, relative to the general population [30, 31]. The QOL score was also 
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lower for the forensic group. Schizophrenic patients are thought to be less satisfied than 
other persons in various QOL domains due to the mental illness itself, 
psychopathological symptoms, and psychosocial factors [32–34]. Substance abuse 
and psychiatric comorbidity are also associated with impaired QOL [35]. 
Forensic psychiatric patients had broader and more severe cognitive problems as 
assessed by the CSB. In Japanese patients with schizophrenia, Yoshida et al. [15] 
reported similar results when using the CSB. The findings of meta-analyses have 
indicated that cognitive impairment in patients with schizophrenia is evident in general 
functioning and across a range of cognitive domains [2, 36, 37]. Thus, cognitive 
impairment is a core feature of schizophrenia. Substance abuse also negatively has 
impacts on cognitive functioning [38, 39].  
Moreover, forensic patients exhibited poorer decision making on the IGT than the 
control group. This finding is supported by most of the literature on patients with 
schizophrenia or substance abuse [40–44]. In accordance with previous reports [45, 46], 
forensic patients in our samples indicated lower net scores in chronologically later 
blocks over the duration of the IGT than controls. Forensic patients were less likely to 
avoid making risky selections during the task, suggesting that they may fail to learn 
from emotional feedback. Deficits in clinical and neuropsychological domains among 
these forensic psychiatric patients are consistent with deficits found in general 
psychiatric patients. 
Although the present study did not compare forensic with non-forensic 
psychiatric patients, several studies have made this comparison [14, 30]. The results of 
these previous studies are inconsistent; some studies showed that forensic patients with 
mental disorders (mostly persons with schizophrenia) had more severe impairment of 
executive functioning [47–49] and general cognitive functioning [50] than non-forensic 
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counterparts. Silver et al. [51] found that forensic patients with schizophrenia showed 
poorer ability to discriminate between intensity levels of facial emotion than their 
non-violent counterparts. From the present study, it is unknown whether their 
performances were different from those of non-forensic patients and whether these are 
related to violence or psychiatric disorders. It should be noted that other variables, 
including the use of medication and substances, might impact neuropsychological 
performance. 
Next, partial correlation analyses were performed to examine the relationship 
between neuropsychological function and violence risk. Demographic and clinical 
variables were controlled because of the possibility that these variables might affect 
neuropsychological functions and violence risk. For the forensic patients, these 
variables included medication dosages, since all patients were in the convalescent or 
rehabilitative stage of treatment. This is the first investigation to demonstrate an 
association between psychopathy and decision making on the IGT in forensic 
psychiatric patients. Even when demographic and clinical variables were controlled, 
poor decision making in both groups was related to psychopathy. Individuals with 
psychopathic traits may be more likely to make risky decisions in ambiguous situations, 
and they fail to learn from emotional feedback to adjust their deviant behavior, 
including violence; this relationship appeared in both groups in our sample. 
Furthermore, poor decision making was more related to the antisocial deviance factor 
(i.e., PCL-R Factor 2) than to the personal/affective factor (PCL-R Factor 1). These 
results were similar to those in previous studies of inmates or nonclinical individuals 
[52–55]. The psychopathic characteristics of antisocial deviance, quick temper, and 
explosive anger tend to have a relatively strong association with poor decision making 
[53, 55]. Performance deficits observed by using the IGT have been linked to lesions in 
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the ventromedial prefrontal cortex (vmPFC) [16]. In addition, individuals with vmPFC 
damage commonly display a syndrome that encompasses poor judgment, socially 
inappropriate behavior, and impulsivity [56]. The IGT is also associated with 
emotion-based decision making and separable from cognitive abilities [57]. 
Alternatively, an association between the CSB composite score and the PCL-R’s 
antisocial deviance factor was marginally significant in forensic patients. These results 
suggest that psychopathic antisocial behavior is more likely to be involved in emotional 
rather than in cognitive processes, although the possibility of an association between 
psychopathic behavior and cognitive processes cannot be ruled out.  
With regard to the other measure of violence risk, the HCR-20, the association 
between the CSB composite score and HCR-20 R score was marginally significant, 
whereas the association with IGT performance was not significant in forensic patients. 
There may be a relationship between violence risk and cognitive impairment as 
measured by the CSB, although the evidence from the present results was insufficient. 
The R scale is related to future risk factors, including exposure to destabilizers, stress, 
and noncompliance with remediation attempts. As Weiss [14] pointed out in her review, 
limitations in executive functioning and/or social recognition would lead to cognitive 
biases that increase the chances of violence in response to stressful and provocative 
situations.  
The present findings imply that different types of neuropsychological impairment 
may lead to violence risk through different but partially overlapping pathways among 
forensic patients with psychiatric disorders. This study suggests that deficits in 
emotional processes related to decision making may contribute to psychopathic 
antisocial behavior. Furthermore, cognitive impairment can cause inadequate responses 
to stressful and provocative situations. As violence can be distinguished between the 
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reactive and instrumental domains, future studies should examine more specific 
associations between the two violence domains and neuropsychological functioning. 
The present study has several limitations. First, it did not compare forensic 
patients with their non-forensic counterparts; therefore, it is unclear whether 
non-forensic patients would exhibit any different neuropsychological and clinical status 
and whether these are related to violence or psychiatric disorders. Second, the group of 
forensic patients was heterogeneous, consisting of 9 patients coded as F1, 61 coded as 
F2, and 1 coded as F3 on the ICD-10. The F1 group included individuals with psychotic 
disorders due to the use of alcohol, cannabinoids, volatile solvents, hallucinogens, or 
multiple drugs, and the F2 group included persons with schizophrenia, schizoaffective 
disorder, or delusional disorder. Further study using a larger sample size for each group 
is needed. Finally, this was a cross-sectional study, and further prospective studies will 
be needed. 
In conclusion, the present study has found that forensic patients with psychiatric 
disorders have a wide range of neuropsychological impairments that result in poor 
functional outcomes. Furthermore, poor emotional decision making was related to 
psychopathy, especially antisocial behavior. Cognitive impairment in forensic patients 
may also be associated with violence risk. Therefore, the treatment of 
neuropsychological impairment in forensic patients with psychiatric disorders is 
necessary to improve functional outcomes and to prevent violence. Moreover, 
understanding the characteristics of a wide variety of types of neuropsychological 
impairment is critical to the development of suitable treatment strategies for each 
forensic patient. 
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